# The VERISMART Trial

Study · id `cardio:ct-nct02490033` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02490033](<https://clinicaltrials.gov/study/NCT02490033>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02490033

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.

## Technical summary

Registry record NCT02490033. Randomized; no masking; primary purpose other. Start 2015-04-01 (registry gives no type); primary completion 2017-01-06 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 133 participants (enrolled count; ClinicalTrials.gov record NCT02490033, source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)
- Start date: 2015-04-01 (registry gives no type) (ClinicalTrials.gov record NCT02490033, source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)
- Primary completion: 2017-01-06 (actual) (ClinicalTrials.gov record NCT02490033, source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)
- Completion: 2018-10-28 (actual) (ClinicalTrials.gov record NCT02490033, source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02490033, source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02490033-2019-08-08`, retrieved 2026-10-26)

## The registry's words

- Brief title: The VERISMART Trial
- Acronym: VERISMART
- Condition: Atrial Flutter
- Intervention (Device): Ablation Catheter
- Lead sponsor: The Leeds Teaching Hospitals NHS Trust
- Lead sponsor class: OTHER
- Collaborator: Biosense Webster, Inc.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial flutter (`cardio:atrial-flutter`)
- Registry lists this organization as the lead sponsor: The Leeds Teaching Hospitals NHS Trust (`cardio:org-the-leeds-teaching-hospitals-nhs-trust`)
- Registry lists this organization as a collaborator: Biosense Webster, Inc. (`cardio:org-biosense-webster-inc`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Multicentre randomised trial comparing contact force with electrical coupling index in atrial flutter ablation (VERISMART trial) (`cardio:pubmed-30943196`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 072184073942c5046bc4097f6de04ad2af04d1a9311a5feb30d2c1f13e1ab6c3
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
